ENTA - ENANTA PHARMACEUTICALS INC
IEX Last Trade
5.94
-0.070 -1.178%
Share volume: 8,431
Last Updated: Thu 26 Dec 2024 08:29:48 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$6.01
-0.07
-1.16%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-08-08 | 2022-11-23 | 2023-02-08 | 2023-05-09 | 2023-08-08 | 2023-11-22 | 2024-02-08 | 2024-05-08 | |
| Total revenue | 19.479 M | 20.317 M | 23.585 M | 17.795 M | 18.892 M | 18.932 M | 18.003 M | 17.054 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 19.479 M | 20.317 M | 23.585 M | 17.795 M | 18.892 M | 18.932 M | 18.003 M | 17.054 M | |
| 4.30% | 16.09% | -24.55% | 6.16% | 0.21% | -4.91% | -5.27% | |||
| Operating expenses | 52.019 M | 47.365 M | 53.598 M | 57.246 M | 55.605 M | 49.962 M | 52.889 M | 49.820 M | |
| Selling general and admin | 12.929 M | 12.569 M | 12.696 M | 13.778 M | 12.618 M | 13.795 M | 16.518 M | 14.235 M | |
| Research and development | 39.090 M | 34.796 M | 40.902 M | 43.468 M | 42.987 M | 36.167 M | 36.371 M | 35.585 M | |
| Total expenses | 52.019 M | 47.365 M | 53.598 M | 57.246 M | 55.605 M | 49.962 M | 52.889 M | 49.820 M | |
| -8.95% | 13.16% | 6.81% | -2.87% | -10.15% | 5.86% | -5.80% | |||
| Operating income | -32.540 M | -27.048 M | -30.013 M | -39.451 M | -36.713 M | -31.030 M | -34.886 M | -32.766 M | |
| Ebit | -32.540 M | -27.048 M | -30.013 M | -39.451 M | -36.713 M | -31.030 M | -34.886 M | -32.766 M | |
| Pretax income | -32.147 M | -26.298 M | -29.020 M | -37.614 M | -34.844 M | -29.517 M | -34.029 M | -31.520 M | |
| -18.19% | 10.35% | 29.61% | -7.36% | -15.29% | 15.29% | -7.37% | |||
| Income tax | -447.000 K | 50.000 K | -34.000 K | 44.000 K | 4.221 M | -1.410 M | -622.000 K | -363.000 K | |
| Net income basic | -31.700 M | -26.348 M | -28.986 M | -37.658 M | -39.065 M | -28.107 M | -33.407 M | -31.157 M | |
| 16.88% | -10.01% | -29.92% | -3.74% | 28.05% | -18.86% | 6.74% | |||
| Net income | -31.700 M | -26.348 M | -28.986 M | -37.658 M | -39.065 M | -28.107 M | -33.407 M | -31.157 M | |
| 16.88% | -10.01% | -29.92% | -3.74% | 28.05% | -18.86% | 6.74% |